12/7
12:36 pm
glpg
Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma [Yahoo! Finance]
Low
Report
Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma [Yahoo! Finance]
12/7
12:30 pm
glpg
Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma
Low
Report
Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma
11/20
07:42 am
glpg
Galapagos NV (NASDAQ: GLPG) was downgraded by analysts at Kepler Capital Markets from a "hold" rating to a "reduce" rating.
Low
Report
Galapagos NV (NASDAQ: GLPG) was downgraded by analysts at Kepler Capital Markets from a "hold" rating to a "reduce" rating.
11/5
04:01 pm
glpg
Galapagos to Present Results of Pioneering Innovation in Cancer Cell Therapy at ASH 2024
Low
Report
Galapagos to Present Results of Pioneering Innovation in Cancer Cell Therapy at ASH 2024
11/1
01:38 pm
glpg
Galapagos NV (NASDAQ: GLPG) had its price target lowered by analysts at Royal Bank of Canada from $32.00 to $30.00. They now have a "sector perform" rating on the stock.
Low
Report
Galapagos NV (NASDAQ: GLPG) had its price target lowered by analysts at Royal Bank of Canada from $32.00 to $30.00. They now have a "sector perform" rating on the stock.
10/30
04:01 pm
glpg
Galapagos Reports Third Quarter 2024 Financial Results and Provides Business Update
Medium
Report
Galapagos Reports Third Quarter 2024 Financial Results and Provides Business Update
10/7
04:54 pm
glpg
Galapagos grants an investor a seat on its board [Seeking Alpha]
Low
Report
Galapagos grants an investor a seat on its board [Seeking Alpha]
10/7
01:00 am
glpg
Galapagos welcomes Oleg Nodelman to its Board of Directors to support strategic growth
Medium
Report
Galapagos welcomes Oleg Nodelman to its Board of Directors to support strategic growth
10/1
06:00 am
glpg
Excellos Selected as Decentralized Manufacturing Unit to Support Galapagos’ CAR-T Cell Therapy Clinical Study Close to Cancer Treatment Centers in the San Diego Area
Low
Report
Excellos Selected as Decentralized Manufacturing Unit to Support Galapagos’ CAR-T Cell Therapy Clinical Study Close to Cancer Treatment Centers in the San Diego Area
9/30
04:01 pm
glpg
Galapagos receives transparency notification from EcoR1 Capital
Low
Report
Galapagos receives transparency notification from EcoR1 Capital